These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1106 related items for PubMed ID: 7715639

  • 1. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR.
    N Engl J Med; 1995 May 18; 332(20):1317-22. PubMed ID: 7715639
    [Abstract] [Full Text] [Related]

  • 2. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov 18; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
    Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP.
    N Engl J Med; 2017 Feb 02; 376(5):429-439. PubMed ID: 27959701
    [Abstract] [Full Text] [Related]

  • 8. [Hydroxyurea treatment in patients affected with sickle cell anemia: efficacy and safety].
    de Montalembert M.
    Transfus Clin Biol; 2008 Feb 02; 15(1-2):34-8. PubMed ID: 18499496
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray.
    Karimi M, Zekavat OR, Sharifzadeh S, Mousavizadeh K.
    Am J Hematol; 2006 Nov 02; 81(11):809-16. PubMed ID: 16941613
    [Abstract] [Full Text] [Related]

  • 11. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1993 Jan 14; 328(2):73-80. PubMed ID: 7677965
    [Abstract] [Full Text] [Related]

  • 12. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Jan 14; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 13. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP, Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    N Engl J Med; 2018 Jul 19; 379(3):226-235. PubMed ID: 30021096
    [Abstract] [Full Text] [Related]

  • 14. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
    Mellouli F, Bejaoui M.
    Arch Pediatr; 2008 Jan 19; 15(1):24-8. PubMed ID: 18164913
    [Abstract] [Full Text] [Related]

  • 15. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
    Griffin TC, McIntire D, Buchanan GR.
    N Engl J Med; 1994 Mar 17; 330(11):733-7. PubMed ID: 8107739
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia].
    Elira Dokekias A, Okandze Elenga JP, Ndinga J, Sanogo I, Sangare A.
    Tunis Med; 2005 Jan 17; 83(1):32-7. PubMed ID: 15881719
    [Abstract] [Full Text] [Related]

  • 18. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1990 Apr 12; 322(15):1037-45. PubMed ID: 1690857
    [Abstract] [Full Text] [Related]

  • 19. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Apr 12; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.